Intraperitoneal vancomycin monitoring sheet


Although previously reported in the literature, the existence of chemical peritonitis due to vancomycin in patients on peritoneal dialysis remains controversial. We report four similar episodes of sterile peritonitis in three patients receiving intraperitoneal (IP) vancomycin. Page 5 of 18 report to Home dialysis unit (ext 2863) between 08.00 and 16.00 Mon-Fri and Grenville ward (ext 2010) any other time. A patient’s first contact with health services may be at the Emergency Department, their NEW ZEALAND DATA SHEET VANCOMYCIN . 1. Product Name Vancomycin 500 mg and 1000 mg powder for infusion. 2. Qualitative and Quantitative Composition Each vial contains 500 mg or 1000 mg of vancomycin base. 3. Pharmaceutical Form . Vancomycin powder for infusion is a white to almost whiteor slightly pink or yellow freezedried - PDR Drug Summaries are concise point-of-care prescribing, dosing and administering information to help phsyicans more efficiently and accurately prescribe in their practice PDR's drug summaries are available free of charge and serve as a great resource for US based MDs, DOs, NPs and PAs in patient practice Dec 08, 2010 · Intraperitoneal vancomycin may be administered as 15 – 30 mg/kg body weight IP every 5-7 days for Intermittent use (per exchange, once daily). For continuous use (all exchanges) the recommendation is a loading dose of 1000mg/L plus a maintenance dose of 25mg/L (Perit Dial Int 2010 30: 393–423). Frequent monitoring (more than one trough before the fourth dose) for short course or lower intensity dosing (trough below 15 mg/l) is not recommendedPatients on prolonged courses of vancomycin ...